Ondansetron Tablet
Product Images NDC 51407-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 51407-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-003-05 (pl).jpg (51407 003 05 (pl))

51407-003-05 (pl).jpg (51407 003 05 (pl))
Each film-coated tablet contains 5 mg of ondansetron hydrochloride dihydrate, equivalent to 4 mg of ondansetron. The tablets should be stored at 20°-25°C (68°-77°F) in a tight, light-resistant container. It is important to refer to the package insert for dosage and administration guidelines. This medication should be kept out of reach of children and has passed USP Dissolution Test 3. Marketed by GSMS, Incorporated in Camarillo, CA 93012, USA.*
FDA Label Image

51407-003-30lb.jpg (51407 003 30lb)

51407-003-30lb.jpg (51407 003 30lb)
This is a description of a pharmaceutical product with the NDC number 51407-003-30. It is a tablet containing 5 mg of ondansetron hydrochloride dihydrate (equivalent to 4 mg of ondansetron). The tablets are film-coated and come in a bottle containing 30 tablets. The product is for prescription use only. The package insert should be referred to for dosage and administration instructions. The storage instructions are to keep the product at 20° - 25°C. It is important to store the tablets in a tight, light-resistant container as per USP guidelines. It is recommended to keep the medication out of the reach of children. The product meets USP Dissolution Test 3 standards. The medication is marketed by GSMS, Incorporated and is produced in Camarillo, CA, USA. (Revision date mentioned: 11/24)*
FDA Label Image

51407-004-05 (pl).jpg (51407 004 05 (pl))

51407-004-05 (pl).jpg (51407 004 05 (pl))
This text provides information about a medication containing ondansetron hydrochloride dihydrate, with each tablet containing 10 mg of the active ingredient. It clarifies that this amount is equivalent to 8 mg of ondansetron. The storage instructions recommend keeping the tablets at 20°-25°C (68°-77°F) and dispensing them in a tight, light-resistant container. The text also mentions the importance of keeping the medication out of the reach of children and states that the product meets USP Dissolution Test 3 standards. Furthermore, it provides details about the manufacturer, GSMS, Incorporated, and includes the GTIN code along with expiration date and lot number information.*
FDA Label Image

51407-004-30lb.jpg (51407 004 30lb)

51407-004-30lb.jpg (51407 004 30lb)
This text provides information about NIL0S 101 ondansetron tablets containing 10 mg of ondansetron hydrochloride dihydrate equivalent to 8 mg of ondansetron. It includes dosage instructions, storage conditions (20° - 25°C), and safety precautions. The product meets USP Dissolution Test 3 standards and is distributed by GSMS, Incorporated.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.